MedTrace Logo

Angiogenic/Angiostatic Mediators in Patients With Systemic Sclerosis

NCT00668473 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2016-10-26

No results posted yet for this study

Summary

We propose to examine several angiogenic/angiostatic mediators in the skin and serum of subjects with SSc and compare it to levels found in the skin and serum of healthy subjects.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Kristine Phillips, MD · University of Michigan

  • James R Seibold, MD · University of Michigan

  • Alisa E Koch, MD · University of Michigan

  • Julie A Konkle, BSN · University of Michigan

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-05-31
Primary Completion
2008-05-31
Completion
2012-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00668473 on ClinicalTrials.gov